Please click on the links below to access the commissioning policies. The associated Equality Impact Assessments, if currently available, are accessible here.
The CCGs’ position on the implementation of policies affecting patient referral can be found here.
Gastrointestinal system - commissioning policiesBudesonide prolonged release multi-matrix tablets (Cortiment®) for ulcerative colitis Botulinum Toxin for the treatment of chronic anal fissure Fidaxomicin (Difliclir®) for the treatment of adults with Clostridium difficile Infection (CDI) Haemorrhoids - referral and specialist management in adults
To access the accompanying Clinical policy patient support information for the haemorrhoids policy please click here.Lecicarbon A suppositories for the management of chronic constipation Linaclotide (Constella®) for the treatment of irritable bowel syndrome with constipation (IBS-C) in adults Radiofrequency ablation for Barrett's oesophagus
Please note: Some commissioning policies approved by the previous commissioning organisations have not been reviewed and updated yet. However they are still applicable for the local population and can be accessed here.